vs
CHIMERA INVESTMENT CORP（CIM）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是CHIMERA INVESTMENT CORP的1.1倍（$75.5M vs $66.2M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 0.5%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 0.8%）
Chimera Investment Corp是一家总部位于美国的房地产投资信托，主要投资住宅抵押贷款支持证券、住宅及商业抵押贷款和其他房地产相关金融资产，聚焦为股东创造经风险调整的可持续回报，通过投资组合运营派发定期股息。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
CIM vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.1倍
$66.2M
营收增速更快
PBYI
高出27.2%
0.5%
两年增速更快
PBYI
近两年复合增速
0.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $66.2M | $75.5M |
| 净利润 | $28.3M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 42.6% | 22.7% |
| 净利率 | 42.8% | — |
| 营收同比 | 0.5% | 27.7% |
| 净利润同比 | 119.3% | — |
| 每股收益（稀释后） | $0.05 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CIMPBYI
| Q4 25 | $66.2M | $75.5M | ||
| Q3 25 | $65.0M | $54.5M | ||
| Q2 25 | $66.0M | $52.4M | ||
| Q1 25 | $69.2M | $46.0M | ||
| Q4 24 | $65.8M | $59.1M | ||
| Q3 24 | $66.5M | $80.5M | ||
| Q2 24 | $67.3M | $47.1M | ||
| Q1 24 | $65.1M | $43.8M |
净利润CIMPBYI
| Q4 25 | $28.3M | — | ||
| Q3 25 | $-580.0K | $8.8M | ||
| Q2 25 | $35.5M | $5.9M | ||
| Q1 25 | $167.3M | $3.0M | ||
| Q4 24 | $-146.5M | — | ||
| Q3 24 | $136.5M | $20.3M | ||
| Q2 24 | $56.7M | $-4.5M | ||
| Q1 24 | $129.5M | $-4.8M |
毛利率CIMPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率CIMPBYI
| Q4 25 | 42.6% | 22.7% | ||
| Q3 25 | -0.5% | 17.6% | ||
| Q2 25 | 54.3% | 12.7% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | -222.6% | 22.6% | ||
| Q3 24 | — | 27.4% | ||
| Q2 24 | 84.2% | -4.6% | ||
| Q1 24 | — | -5.3% |
净利率CIMPBYI
| Q4 25 | 42.8% | — | ||
| Q3 25 | -0.9% | 16.2% | ||
| Q2 25 | 53.7% | 11.2% | ||
| Q1 25 | 241.7% | 6.5% | ||
| Q4 24 | -222.6% | — | ||
| Q3 24 | 205.4% | 25.2% | ||
| Q2 24 | 84.2% | -9.6% | ||
| Q1 24 | 198.8% | -11.0% |
每股收益（稀释后）CIMPBYI
| Q4 25 | $0.05 | $0.26 | ||
| Q3 25 | $-0.27 | $0.17 | ||
| Q2 25 | $0.17 | $0.12 | ||
| Q1 25 | $1.77 | $0.06 | ||
| Q4 24 | $-2.06 | $0.40 | ||
| Q3 24 | $1.39 | $0.41 | ||
| Q2 24 | $0.41 | $-0.09 | ||
| Q1 24 | $1.36 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $278.6M | $97.5M |
| 总债务越低越好 | $251.5M | $22.7M |
| 股东权益账面价值 | $2.6B | $130.3M |
| 总资产 | $15.8B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.10× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资CIMPBYI
| Q4 25 | $278.6M | $97.5M | ||
| Q3 25 | $491.5M | $94.4M | ||
| Q2 25 | $250.2M | $96.0M | ||
| Q1 25 | $253.3M | $93.2M | ||
| Q4 24 | $84.0M | $101.0M | ||
| Q3 24 | $97.3M | $96.7M | ||
| Q2 24 | $162.3M | $96.8M | ||
| Q1 24 | $169.0M | $107.2M |
总债务CIMPBYI
| Q4 25 | $251.5M | $22.7M | ||
| Q3 25 | $251.0M | $34.0M | ||
| Q2 25 | $135.2M | $45.3M | ||
| Q1 25 | $134.9M | $56.7M | ||
| Q4 24 | $134.6M | $68.0M | ||
| Q3 24 | $134.4M | $79.3M | ||
| Q2 24 | $62.4M | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益CIMPBYI
| Q4 25 | $2.6B | $130.3M | ||
| Q3 25 | $2.6B | $115.3M | ||
| Q2 25 | $2.6B | $104.7M | ||
| Q1 25 | $2.6B | $97.1M | ||
| Q4 24 | $2.5B | $92.1M | ||
| Q3 24 | $2.7B | $71.1M | ||
| Q2 24 | $2.6B | $48.5M | ||
| Q1 24 | $2.6B | $51.0M |
总资产CIMPBYI
| Q4 25 | $15.8B | $216.3M | ||
| Q3 25 | $15.1B | $202.9M | ||
| Q2 25 | $14.9B | $194.9M | ||
| Q1 25 | $13.2B | $196.2M | ||
| Q4 24 | $13.1B | $213.3M | ||
| Q3 24 | $13.7B | $220.7M | ||
| Q2 24 | $13.1B | $205.0M | ||
| Q1 24 | $12.5B | $214.1M |
负债/权益比CIMPBYI
| Q4 25 | 0.10× | 0.17× | ||
| Q3 25 | 0.10× | 0.30× | ||
| Q2 25 | 0.05× | 0.43× | ||
| Q1 25 | 0.05× | 0.58× | ||
| Q4 24 | 0.05× | 0.74× | ||
| Q3 24 | 0.05× | 1.12× | ||
| Q2 24 | 0.02× | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-248.9M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | -8.78× | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流CIMPBYI
| Q4 25 | $-248.9M | $14.4M | ||
| Q3 25 | $-137.5M | $9.7M | ||
| Q2 25 | $-7.4M | $14.1M | ||
| Q1 25 | $48.8M | $3.6M | ||
| Q4 24 | $205.7M | $15.6M | ||
| Q3 24 | $41.4M | $11.0M | ||
| Q2 24 | $69.0M | $1.0M | ||
| Q1 24 | $57.3M | $11.2M |
自由现金流CIMPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率CIMPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度CIMPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率CIMPBYI
| Q4 25 | -8.78× | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | -0.21× | 2.41× | ||
| Q1 25 | 0.29× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.30× | 0.54× | ||
| Q2 24 | 1.22× | — | ||
| Q1 24 | 0.44× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
